2024 Global Gene Therapy Training

Applications are now closed.

This free certificate-awarding course will equip participants with the necessary knowledge and skills to educate students on the advances in gene therapy. The course is being offered by ASGCT in collaboration with Muhimbili University of Health and Allied Sciences as part of ASGCT’s goal to provide global audiences with accurate and up-to-date information through educational and training programs that increase awareness and understanding of gene and cell therapy.

What to Expect

Watch a preview of a course from 2023.

Course Structure

This course is for academic faculty teaching at accredited universities or medical schools in sub-Saharan Africa. The course aims to train faculty with the necessary knowledge and skills to implement gene therapy education into their university and medical school curricula. 

Each 1.5-hour class will consist of a 60-minute lecture, followed by 30 minutes of discussion. Participants will be able to chat live with the instructors during the entire lecture. Expert members of ASGCT will instruct the eight-part course. Required readings for each class will be available upon acceptance into the course. Each class will conclude with a multiple-choice test, which must be completed to earn a certificate.  


(1.5 hours each)

  • June 4: Genetics of human disorders   

  • June 5 + 6: Gene therapy overview parts 1&2 

  • June 11: Methods for correcting genetic diseases 

  • June 12: Use of gene therapy in cancer treatment   

  • June 13: Current status of clinical gene therapy 

  • June 20: Ethical issues, regulatory challenges, and the role of patient advocacy groups and international partnerships in implementing gene therapies 

  • June 21: How to initiate a clinical trial 


Participants completing the course will learn:

  1. Methods used in genetic modification of human tissues   

  2. Major disease targets for clinical gene therapies  

  3. Ethical and regulatory challenges to gene therapies  

  4. Limitation and opportunities for equitable access to gene therapy 


At the conclusion of the course the participant will be able to:

  1. Explain the methods used in clinical gene therapy   

  2. Summarize the status of gene therapy clinical trials  

  3. Critique the ethical and regulatory issues regarding genetic modification of human tissues  

  4. Create educational materials to educate trainees on the current status of clinical gene therapy


Participants are expected to attend at least four of the eight classes live during the scheduled class time and watch the remaining classes on-demand before the next live class begins. Participants must complete all eight tests. Participants who meet these requirements will receive a certificate from MUHAS and ASGCT. All modules will be recorded and available on-demand for participants to reference after the completion of the course.

Apply for the Global Gene Therapy Training course


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.